When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
ALRN - Aileron concludes enrollment in dose optimization expansion cohort in early stage study of chemotherapeutic agent
Aileron Therapeutics Inc.
Aileron Therapeutics (NASDAQ:ALRN)+8% premarket, after the company completed enrollment in dose optimization expansion cohort of its Phase 1b study of ALRN-6924.
More news on: Aileron Therapeutics, Inc., Healthcare stocks news, Stocks on the move,